These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31235377)

  • 1. Therapy-related acute lymphoblastic leukemia: Where do we stand with regards to its definition and characterization?
    Aldoss I; Douer D; Pullarkat V
    Blood Rev; 2019 Sep; 37():100584. PubMed ID: 31235377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to
    Aldoss I; Stiller T; Tsai NC; Song JY; Cao T; Bandara NA; Salhotra A; Khaled S; Aribi A; Al Malki MM; Mei M; Ali H; Spielberger R; O'Donnell M; Snyder D; Slavin T; Nakamura R; Stein AS; Forman SJ; Marcucci G; Pullarkat V
    Haematologica; 2018 Oct; 103(10):1662-1668. PubMed ID: 29903756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.
    Saygin C; Kishtagari A; Cassaday RD; Reizine N; Yurkiewicz I; Liedtke M; Stock W; Larson RA; Levine RL; Tallman MS; Park JH; Kerr C; Przychodzen B; Sekeres MA; Kalaycio ME; Carraway HE; Hamilton BK; Sobecks R; Gerds A; Mukherjee S; Nazha A; Maciejewski JP; Advani AS
    Blood Adv; 2019 Dec; 3(24):4228-4237. PubMed ID: 31869410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children.
    Felix CA; Hosler MR; Slater DJ; Parker RI; Masterson M; Whitlock JA; Rebbeck TR; Nowell PC; Lange BJ
    J Pediatr Hematol Oncol; 1998; 20(4):299-308. PubMed ID: 9703001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemia.
    Metzler M; Strissel PL; Strick R; Niemeyer C; Roettgers S; Borkhardt A; Harbott J; Ludwig WD; Stanulla M; Schrappe M; Reinhardt D; Creutzig U; Beck JD; Rascher W; Repp R; Langer T
    Genes Chromosomes Cancer; 2004 Nov; 41(3):291-6. PubMed ID: 15334554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HRX gene rearrangement in secondary acute lymphoblastic leukemia.
    Kobayashi Y; Hayashi Y; Ozawa K; Asano S
    Leuk Lymphoma; 1995 May; 17(5-6):391-9. PubMed ID: 7549829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related acute lymphoblastic leukemia with MLL rearrangement following treatment of Burkitt's leukemia.
    Millot F; Brizard F; Sorel N; Preudhomme C; Cividin M; Guilhot F; Brizard A
    Leuk Lymphoma; 2005 Jun; 46(6):925-7. PubMed ID: 16019540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
    Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Brunet S; Bergua J; Tormo M; García-Boyero R; Sarrà J; Del Potro E; Grande C; Barba P; Bernal T; Amigo ML; Grau J; Cervera J; Feliu E;
    Leuk Lymphoma; 2017 Jan; 58(1):145-152. PubMed ID: 27122129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-related B-lymphoblastic leukemia associated with Philadelphia chromosome and MLL rearrangement: Single institution experience and the review of the literature.
    Matnani R; Parekh V; Borate U; Brazelton J; Reddy V; Peker D
    Pathol Int; 2015 Oct; 65(10):536-40. PubMed ID: 26259760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic conversion from t(8;21) acute myeloid leukemia to MLL gene rearrangement-positive acute lymphoblastic leukemia.
    Ohsaka A; Kato K; Hikiji K
    Hematopathol Mol Hematol; 1998; 11(3-4):185-92. PubMed ID: 9844825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia.
    Sugita K; Taki T; Hayashi Y; Shimaoka H; Kumazaki H; Inoue H; Konno Y; Taniwaki M; Kurosawa H; Eguchi M
    Genes Chromosomes Cancer; 2000 Mar; 27(3):264-9. PubMed ID: 10679915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLL partner genes in secondary acute lymphoblastic leukemia: report of a new partner PRRC1 and review of the literature.
    Douet-Guilbert N; Eveillard JR; Meyer C; Ugo V; Le Bris MJ; Basinko A; Morel F; Marschalek R; De Braekeleer M
    Leuk Res; 2014 Nov; 38(11):1316-9. PubMed ID: 25205603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
    Chowdhury T; Brady HJ
    Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
    Pui CH; Behm FG; Downing JR; Hancock ML; Shurtleff SA; Ribeiro RC; Head DR; Mahmoud HH; Sandlund JT; Furman WL
    J Clin Oncol; 1994 May; 12(5):909-15. PubMed ID: 8164041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute leukemia in children.
    Pui CH
    Curr Opin Hematol; 1996 Jul; 3(4):249-58. PubMed ID: 9372085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.
    Tomizawa D; Koh K; Sato T; Kinukawa N; Morimoto A; Isoyama K; Kosaka Y; Oda T; Oda M; Hayashi Y; Eguchi M; Horibe K; Nakahata T; Mizutani S; Ishii E
    Leukemia; 2007 Nov; 21(11):2258-63. PubMed ID: 17690691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
    Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
    Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.